vimarsana.com
Home
Live Updates
Mimivax Inc - Breaking News
Pages:
Latest Breaking News On - Mimivax inc - Page 1 : vimarsana.com
MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma
/PRNewswire/ MimiVax, Inc., a biotechnology company focused on the development of SurVaxM, a survivin-targeted vaccine therapy for glioblastoma and other.
United states
John higgins
Scott davis
Michael ciesielski
National brain tumor society
Sontag innovation fund
Mimivax inc
Sontag foundation
Brain tumor investment fund
Sontag innovation the
Varia ventures
Clinical oncology
Managing director
Tech coast angels
North america
Sontag innovation
FDA Grants Fast Track Designation to SurVaxM for Newly Diagnosed Glioblastoma
The brain cancer vaccine SurVaxM is among the novel treatments currently being studied for patients with glioblastoma.
United states
New york
Michael ciesielski
Roswell park
Mimivax inc
Roswell park comprehensive cancer center
Drug administration
American brain tumor association
Fast track designation
Brain cancer made me feel fortunate
Clinical oncology
Craft brewing community uses
Cancer awareness
Orphan drug designation
Track designation
American brain tumor
vimarsana © 2020. All Rights Reserved.